Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $722.89 | 40 | 92.7% |
| Debt forgiveness | $57.00 | 1 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $196.01 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $130.38 | 7 | $0 (2020) |
| Welch Allyn | $57.00 | 1 | $0 (2021) |
| Lilly USA, LLC | $54.08 | 3 | $0 (2024) |
| Novo Nordisk Inc | $53.44 | 3 | $0 (2023) |
| ABBVIE INC. | $47.18 | 3 | $0 (2024) |
| Amgen Inc. | $40.14 | 2 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $38.17 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.41 | 1 | $0 (2022) |
| Lundbeck LLC | $23.55 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.38 | 6 | Supernus Pharmaceuticals, Inc. ($88.77) |
| 2023 | $186.08 | 10 | Supernus Pharmaceuticals, Inc. ($70.65) |
| 2022 | $94.93 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.41) |
| 2021 | $69.25 | 2 | Welch Allyn ($57.00) |
| 2020 | $56.25 | 3 | Otsuka America Pharmaceutical, Inc. ($40.59) |
| 2019 | $51.85 | 3 | Amgen Inc. ($24.48) |
| 2018 | $88.47 | 6 | Otsuka America Pharmaceutical, Inc. ($29.33) |
| 2017 | $109.68 | 6 | Otsuka America Pharmaceutical, Inc. ($60.46) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $40.26 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.45 | General |
| Category: PSYCHOLOGY | ||||||
| 11/08/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: PSYCHOLOGY | ||||||
| 10/18/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: PSYCHOLOGY | ||||||
| 10/13/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/21/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: PSYCHOLOGY | ||||||
| 09/14/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Neuropsychiatry | ||||||
| 06/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Diabetes | ||||||
| 04/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Obesity | ||||||
| 02/09/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 10/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: PSYCHOLOGY | ||||||
| 05/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Diabetes | ||||||
| 03/10/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2021 | Welch Allyn | None (Device) | Debt forgiveness | Cash or cash equivalent | $57.00 | General |
| Category: Not Applicable | ||||||
| 10/13/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 10/08/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 69 | 108 | $2,433 | $719.91 |
| 2022 | 3 | 78 | 121 | $2,651 | $796.04 |
| 2021 | 3 | 82 | 102 | $2,962 | $944.76 |
| 2020 | 5 | 120 | 144 | $4,012 | $1,210 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 58 | $1,434 | $552.16 | 38.5% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 23 | 35 | $793.00 | $134.75 | 17.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 15 | $206.00 | $33.00 | 16.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 39 | 62 | $1,488 | $592.76 | 39.8% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 28 | 44 | $968.00 | $170.12 | 17.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 15 | $195.00 | $33.16 | 17.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 33 | 45 | $1,080 | $436.95 | 40.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 25 | 30 | $1,306 | $401.70 | 30.8% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 24 | 27 | $576.00 | $106.11 | 18.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 36 | 42 | $1,722 | $558.33 | 32.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 38 | 47 | $1,128 | $454.28 | 40.3% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 22 | 25 | $500.00 | $98.09 | 19.6% |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or m | Office | 2020 | 12 | 14 | $470.00 | $63.60 | 13.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 12 | 16 | $192.00 | $35.60 | 18.5% |
About Dr. Tyson Lahti, DO
Dr. Tyson Lahti, DO is a Pediatrics healthcare provider based in Muskegon, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477814846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyson Lahti, DO has received a total of $779.89 in payments from pharmaceutical and medical device companies, with $123.38 received in 2024. These payments were reported across 41 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($722.89).
As a Medicare-enrolled provider, Lahti has provided services to 349 Medicare beneficiaries, totaling 475 services with total Medicare billing of $3,671. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Muskegon, MI
- Active Since 06/01/2012
- Last Updated 04/01/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1477814846
Products in Payments
- REXULTI (Drug) $153.93
- Qelbree (Drug) $88.77
- QELBREE (Drug) $86.04
- None (Device) $57.00
- VRAYLAR (Drug) $47.18
- MOUNJARO (Drug) $41.83
- Aimovig (Biological) $40.14
- INGREZZA (Drug) $38.17
- STIOLTO RESPIMAT (Drug) $25.41
- BEXSERO (Biological) $21.55
- TROKENDI XR (Drug) $21.20
- Rybelsus (Drug) $20.54
- Saxenda (Drug) $18.36
- NEXPLANON (Drug) $15.81
- Fanapt (Drug) $15.34
- VYVANSE (Drug) $14.58
- Ozempic (Drug) $14.54
- Adzenys XR-ODT (Drug) $12.66
- TRULICITY (Drug) $12.25
- LYRICA (Drug) $12.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Muskegon
Dr. Marisha Agana, M.d., Mph, M.D., MPH
Pediatrics — Payments: $3,805
Elizabeth Pallante, M.d, M.D
Pediatrics — Payments: $1,367
Richard Golz, M.d, M.D
Pediatrics — Payments: $1,321
Dr. Marco Tatangelo, M.d, M.D
Pediatrics — Payments: $836.88
Dr. Robington Woods, D.o, D.O
Pediatrics — Payments: $481.14
Jennifer King, Md, MD
Pediatrics — Payments: $148.90